Shareholders meeting

July 10, 2026 Listing Department Code: 532321 L isting Department Code: ZYDUSLIFE BSE Limited National Stock Exchange of India Limited P.J. Towers, Dalal Street Exchange Plaza, Plot No. C/1, G Block, Mumbai-400001 Bandra-Kurla Complex, Bandra (East), Mumbai-400051 Re: Annual General Meeting and Integrated Annual Report for the Financial Year ended on March 31, 2026 Dear Sir / Madam, Pursuant to regulation 34(1) of The Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are submitting herewith the Integrated Annual Report of the Company along with the Notice of Thirty First Annual General Meeting (“AGM”) for the Financial Year ended on March 31, 2026, which is being sent to the members through electronic means as per the circulars from Ministry of Corporate Affairs and The Securities and Exchange Board of India. Important details with regard to AGM are as under: Sr. No. Particulars Details Day: Tuesday Date: August 11, 2026 1. AGM details Time: 10:00 a.m. (IST) Through Video Conference / Other Audio Visual Means Cut-off date to determine list of members entitled 2. Friday, July 3, 2026 to receive Notice of AGM and Integrated Report Cut-off date to determine list of members entitled 3. Friday, July 24, 2026 to receive final dividend 4. Dividend Payment Date On or around Friday, August 14, 2026 Cut-off date to determine list of members entitled 5. Tuesday, August 4, 2026 for e-voting 6. Remote e-voting start time, day and date 9.00 a.m. (IST), Saturday, August 8, 2026 7. Remote e-voting end time, day and date 5.00 p.m. (IST), Monday, August 10, 2026 The link to view the Notice of AGM and Integrated Annual Report is as under: https://www.zyduslife.com/investor/admin/uploads/14/2/2025-2026.pdf Please receive the same in order. Thanking you, Yours faithfully, For, Zydus Lifesciences Limited Dhaval N. Soni Company Secretary and Compliance Officer Membership No. FCS7063 Encl.: As above Scaling Innovation Redefining Care Delivering Value Integrated Annual Report 2025-26 Corporate INTERNAL AUDITORS Ernst & Young LLP R&D CENTRES Chartered Accountants Information Mumbai Zydus Research Centre (ZRC) Survey No. 396/403, Sarkhej-Bavla REGISTERED AND N.H. No. 8A, Moraiya, CORPORATE OFFICE Ahmedabad-382213 BOARD OF COMMITTEES OF STAKEHOLDERS’ / INVESTORS’ Zydus Corporate Park PHARMACEUTICAL TECHNOLOGY CENTRE (PTC) DIRECTORS THE BOARD AND RELATIONSHIP COMMITTEE Scheme No. 63, Survey No. 536, Pankaj R. Patel THEIR CONSTITUTION: Mukesh M. Patel, Chairperson Khoraj (Gandhinagar), Plot No. 417, 419, 420, Near Vaishnodevi Circle, Sarkhej-Bavla N.H. No. 8A, Audit Committee Pankaj R. Patel Chairman Sarkhej Gandhinagar Highway, Moraiya, Ahmedabad-382210 Akhil A. Monappa, Chairperson Dr. Sharvil P. Patel Ahmedabad-382481 Bhadresh K. Shah Bhadresh K. Shah Bhadresh K. Shah ZYDUS ACTIVE PHARMACEUTICAL INGREDIENTS (API) PARK Independent Director Shelina P. Parikh REGISTRAR AND SHARE Shelina P. Parikh Kulin S. Lalbhai SHARE TRANSFER COMMITTEE TRANSFER AGENTS Survey No. 233, 234/2, 236/1, 237/1, Tandalja, Behind Bright Day CBSE School, Pankaj R. Patel, Chairperson Vasna Bhayali Canal Road, Vadodara-390002 Independent Woman Director MUFG Intime India Private Limited NOMINATION AND Dr. Sharvil P. Patel Akhil A. Monappa REMUNERATION (formerly known as Link Intime India PHARMACEUTICAL TECHNOLOGY CENTRE (PTC) Ganesh N. Nayak Independent Director COMMITTEE Private Limited) 265/266/267, Sarkhej-Bavla N.H. No. 8A, Opp. Laxminarayan Petrol Pump, Bhadresh K. Shah, Chairperson FINANCE AND ADMINISTRATION 506-508, Amarnath Business Centre-1 Upasana K. Konidela Sanand, Ahmedabad-382213 Akhil A. Monappa COMMITTEE (ABC-1), Besides Gala Business Centre, Independent Woman Director Upasana K. Konidela Pankaj R. Patel Off C G Road, Ellisbridge, VACCINE TECHNOLOGY CENTRE (VTC) Kulin S. Lalbhai Kulin S. Lalbhai Ahmedabad-380006 Dr. Sharvil P. Patel Plot No. 23, 25/P, 37, 40/P, 42, Independent Director Ganesh N. Nayak CORPORATE SOCIAL Sarkhej-Bavla N.H. No. 8A, (effective May 19, 2026) * MANUFACTURING FACILITIES RESPONSIBILITY AND Opp. Ramdev Masala, Changodar, STATUTORY AUDITORS Mukesh M. Patel ENVIRONMENT SOCIAL Human Formulations Sanand, Ahmedabad-382213 Non-Executive Director AND GOVERNANCE COMMITTEE Deloitte Haskins & Sells LLP Plot No. 417, 419, 420, Sarkhej- Chartered Accountants Dr. Sharvil P. Patel Pankaj R. Patel, Chairperson Ahmedabad Bavla N.H. No. 8A, Moraiya, Dr. Sharvil P. Patel Ahmedabad-382210 Managing Director and Shelina P. Parikh (Formulations and Vaccines) Key Managerial Personnel SECRETARIAL AUDITORS Upasana K. Konidela Plot No. 254-255, Behind Zyfine Unit, Plot No. 254-255, Behind Zyfine Unit, SPANJ & Associates Swaraj Majra, Juddi Kalan, Baddi, Ganesh N. Nayak Opp. Lakshminarayan Petrol Pump, Opp. Lakshminarayan Petrol Pump, Tehsil-Nalagarh, District-Solan, RISK MANAGEMENT COMMITTEE Practicing Company Secretaries Sarkhej-Bavla N.H. No. 8A, Changodar, Sarkhej-Bavla N.H. No. 8A, Changodar, Director Himachal Pradesh-173205 Pankaj R. Patel, Chairperson Ahmedabad Sanand, Ahmedabad-382210 Sanand, Ahmedabad-382210 Plot No. 203-213, KEY MANAGERIAL PERSONNEL Dr. Sharvil P. Patel COST AUDITORS Kundaim Industrial Estate, Kundaim, Survey No. 434/6/B & 434/1/K, Jarod, Plot No. 265, 266, 267 (OTHER THAN DIRECTORS) Akhil A. Monappa Waghodia, Vadodara-391510 Opp. Laxminarayan Petrol Pump, R. Nanabhoy & Co. Ponda, Goa-403115 Tushar D. Shroff Kulin S. Lalbhai Cost Accountants Sarkhej-Bavla N.H. No. 8A, Plot No. 1A/1 & 2, Pharma SEZ Sarkhej- Active Pharmaceutical Ingredients Changodar, Tal.: Sanand Chief Financial Officer Mukesh M. Patel Mumbai Bavla N.H. No. 8, Matoda, Sanand, 291, GIDC Industrial Estate, Dist. Ahmedabad-382210 Dhaval N. Soni Tushar D. Shroff Ahmedabad-382213 Ankleshwar-393002 Plot No. N-15, Additional M.I.D.C, Company Secretary Plot No. 1A, Pharma SEZ Sarkhej- Plot No. 5/1-B, GIDC Industrial Estate, Ambernath, Maharashtra 421506 Bavla N.H. No. 8, Matoda, Sanand, KEY CONTACTS Ankleshwar-393002 Ahmedabad-382213 Biological Products and Vaccines Arvind Bothra Plot No. 26-29, 31, Plot No. 1B, Pharma SEZ Sarkhej- Plot No. 23, 25/P, 37, 40/P, Dabhasa Umraya Road, Head - Investor Relations Bavla N.H. No. 8, Matoda, Sanand, 42 to 47, Sarkhej-Bavla N.H. No. 8A, Dabhasa, Padra, Vadodara-391440 arvind.bothra@zyduslife.com Ahmedabad-382213 Opp. Ramdev Masala, Changodar, Plot No. 162, Ekalbara Road, Sanand, Ahmedabad-382213 Dhaval N. Soni Dabhasa, Padra, Vadodara-391440 dhavalsoni@zyduslife.com * subject to approval of shareholders at the ensuing annual general meeting. Contents 08 167 Corporate Overview Statutory Reports Page 08 Page 167 10 About Zydus Lifesciences 168 Management Discussion & Analysis 12 Expanding Reach 188 Board’s Report 14 Chairman’s Message 223 Corporate Governance Report 260 Business Responsibility & Sustainability Report Strategic Review Page 18 20 Value Creation Model 22 Stakeholder Engagement 27 Materiality 30 Risk Management 36 Sustainability Financial Statements Capital-wise Review Page 306 Page 42 As a global lifesciences 306 Standalone Financial Statements organisation, we remain 44 Intellectual Capital 389 Consolidated Financial Statements committed to unlocking 58 Financial Capital 488 Statement under section 129(3) 64 Manufactured Capital new possibilities in 80 Human Capital lifesciences through 104 Natural Capital Notice of AGM pathbreaking discoveries 122 Relationship Capital You can also find this report online: that impact lives. 140 Social Capital https://www.zyduslife.com/investor/ 493 Notice admin/uploads/14/2/2025-2026.pdf Page 14 Our Board of Directors Other Disclosures Page 160 Awards & Recognitions Scan QR code 524 Alignment with GRI and other Global ESG Frameworks to see this report online 530 Glossary of Abbreviations Page 165 Zydus Lifesciences Limited CORPORATE OVERVIEW Integrated Annual Report 2025-26 About the Report About REPORTING GUIDELINES AND FRAMEWORKS FEEDBACK INVITATION the R [Showing first 8,000 characters — download PDF for full document]